Abstract: A novel process is disclosed for extruding an absorbable glycolide/lactide block copolymer into multifilament suture fibers. The block copolymer preferably consists of about 50/50 mole % of Glycolide/Lactide in the center segment and the overall composition of the copolymer is about 90/10 mole % Glycolide/Lactide. The novel extrusion process comprises the steps of maintaining the temperatures of at least two, preferably three or more, of the extrusion zones in the range of about 5-50° C. below the polymer melting point. The multifilament suture made with the invention process from the segmented, glycolide-rich, poly(glycolide-co-lactide) copolymers of A-B-A type, where the B-segment is an amorphous prepolymer of glycolide and lactide in the molar ratio of about 50/50 glycolide/lactide, exhibit exceptionally high breaking strength retention (BSR) at 42 days post-implantation.

Abstract: The invention relates to novel processes for the lamination of semi-crystalline, high-melting point, low glass transition polymeric films, which are extruded and subsequently laminated on various thermally sensitive substrates to form laminated medical device constructs in a specific time interval to allow low processing temperatures to avoid polymer film and/or substrate degradation or heat-related distortions. Also disclosed are laminated medical device constructs made from such processes.

Abstract: A method of making a barbed microcatheter having fluid egress openings includes obtaining a barbed microcatheter blank having a hollow tube with a proximal end, a distal end, and an elongated lumen that extends between the proximal and distal ends of the hollow tube, and first and second flattened regions that extend along opposite sides of the hollow tube. The method includes removing material from the first and second flattened regions of the barbed microcatheter blank to form barbs projecting outwardly from the opposite sides of the hollow tube, and using cutting elements for forming fluid egress openings in a wall of the hollow tube that are in fluid communication with the elongated lumen of the hollow tube. The method includes forming a tissue anchor that is connected with the proximal end of the hollow tube, and securing a surgical needle with the distal end of the hollow tube.

Abstract: Provided are pharmaceutical foam compositions comprising a peptone, a peptide hydrolysate or an enzymatically-hydrolyzed protein prepared by enzymatic hydrolysis of a full-length protein; methods of preparation and uses thereof.

Abstract: Novel absorbable foams, lyophilizing solutions, and lyophilizing and annealing processes are disclosed. The foams are made from copolymers of glycolide and epsilon-caprolactone. The foams are useful in or as implantable medical devices.

Abstract: A suture needle container includes a receptacle having a proximal end with an opening and a closed distal end. A hollow mandrel is disposed inside the receptacle. The mandrel projects from the closed distal end toward the opening at the proximal end of the receptacle. The mandrel includes a tubular wall having a proximal end aligned with the proximal end of the receptacle and a distal end connected with the closed distal end of the receptacle. An elongated slot is formed in the tubular wall. A suture needle is disposed within the elongated slot. A suture is secured to the proximal end of the suture needle and wrapped around the hollow mandrel. A cover closes the opening at the proximal end of the receptacle for sealing the suture needle and the suture inside the receptacle for maintaining a sterile environment inside the receptacle.

Abstract: Combination cellulose materials and methods of making and using these materials. The combination material includes a first cellulosic material and a second cellulosic material.

Abstract: Novel surgical sutures and novel medical devices made from novel semi-crystalline, glycolide-rich A-B-A triblock copolymers of glycolide and lactide, wherein said B-segment is a fully amorphous random copolymer of glycolide and lactide, for long term medical applications are disclosed. The novel polymer compositions are useful for long term absorbable surgical sutures, meshes and other medical devices, especially for patients with compromised healing. The novel sutures have improved properties and improved breaking strength retention, while still substantially absorbing within about a 120-day period post-implantation.

Abstract: A system for testing substrates includes a first elongated member including an outer end, an inner end, an outer surface that extends between the outer and inner ends, and a concave surface at the inner end, and a second elongated member including an outer end, an inner end, an outer surface that extends between the outer and inner ends of the second elongated member, and a convex surface at the inner end of the second elongated member that opposes the concave surface at the inner end of the first elongated member. A joint interconnects the first and second elongated members for guiding sliding movement of the concave surface of the first elongated member over the convex surface of the second elongated member between extended and flexed positions. A first clamping assembly is coupled with the first elongated member and at least one first clamping assembly spring normally urges the first clamping assembly away from the inner end of the first elongated member.

Abstract: Provided is an antimicrobial composition comprised of at least one degradation product of oxidized cellulose (OC), such as oxidized regenerate cellulose (ORC), and minocycline, methods of preparation thereof and uses thereof.

Abstract: The present invention is directed methods of making absorbable poly(p-dioxanone) pellets by melt polymerization of p-dioxanone conducted in a single reactor with a temperature regulator by charging a melt reactor with a mixture of p-dioxanone (PDO) monomer, initiator, catalyst, and optionally a dye; melt polymerizing the mixture in the melt reactor with sufficient agitation of the mixture to allow complete mixing of the monomer and for sufficient time to form a PDO polymer product having an unreacted PDO monomer content of at least 65 mole percent; placing the PDO polymer product under a vacuum to remove at least portion of unreacted PDO; discharging the PDO polymer product from the melt reactor directly into an in-line, underwater pelletizer to produce undried PDO pellets, collecting the undried PDO pellets, and storing the collected PDO pellets in the freezer or a vacuum chamber prior to drying.

Abstract: Provided herein are systems for preparing and delivering fibrin sealant to a surface and methods of use thereof. In one embodiment, the system comprises: a. a quantity of a liquid mixture disposed within a container, the mixture comprising: I. fibrin or II. fibrinogen and Factor II; and b. a resin bed disposed within a vessel, the vessel capable of being in fluid communication with the container, wherein when in fluid communication, passage of the mixture through the vessel results in modification of the concentration of small molecules inhibitor(s) and/or inducer(s) within the mixture, favoring fibrin clot formation.

Abstract: A novel two-step process for batch coating surgical needles with cross-linked silicone coatings is disclosed. The surgical needles are cured using a two-step process. The coatings on the needles are partially cured in the first step and mechanically separated. The coatings on the needles are then fully cured in the second step.

Abstract: The present invention relates to improved hemostatic compositions comprising cellulose-based fibers supplemented with compounds, preparation and use thereof.

Abstract: The present invention is directed to a hemostatic semi-solid paste material comprising a bioabsorbable carrier hemostatic material; and a supplemental hemostatic agent; wherein the paste material has an elongated form extending along a lengthwise axis with an aspect ratio of at least 3; wherein the paste is self-supporting and syringe extrudable; and wherein the supplemental hemostatic agent has a non-homogenous distribution profile across a cross-section taken across the lengthwise axis. In another aspect, the present invention relates to devices for forming and expressing the hemostatic material.

Abstract: The present invention is directed to a device for delivering a sealant to a tissue, comprising a sealant compartment, a cooling gas compartment, and a heater, all disposed inside a unified housing; with heater configured for rendering the sealant liquid or semi-liquid or molten and flowable; with sealant compartment configured for expressing the sealant in a flowable form from device via an exit nozzle; with gas compartment configured for expressing a cooling gas via a gas expression port; with exit nozzle and gas expression port co-directed into the same direction.

Abstract: A drug-eluting self-retaining suture comprises a filament, a plurality of retainers, and a drug impregnated in or coated on the filament. The shape and distribution of retainers modifies the in vivo release kinetics of the drug. The drug release kinetics may be modified uniformly or region by region. The self-retaining suture may for example be used for reattaching severed nerves and release nerve growth factor or other regeneration accelerating agents into the region of the nerve injury.

Abstract: The invention relates to a hemostatic composition comprising a mixture of cellulose-based short and long fibers, preparation and use thereof.